Staffhorst, Germany

Sabine Willenkamp


Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2010-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Sabine Willenkamp

Introduction

Sabine Willenkamp is a pioneering inventor based in Staffhorst, Germany. With a focus on advancements in medical technology, she holds two patents that contribute significantly to the field of intraocular brachytherapy.

Latest Patents

Willenkamp's notable patents include methods and apparatuses for intraocular brachytherapy. The invention comprises a hand-held delivery device designed to advance a radiation source into a cannula or probe positioned adjacent to the target tissue. This innovative apparatus features a handpiece that allows for the shielded storage of the radiation source when it is retracted from the cannula. Additionally, the device incorporates a slider mechanism for both advancing and retracting the radiation source. Furthermore, the radiation source is mounted on a wire that has a flexible distal end and a relatively stiffer proximal end. The invention also includes a positioning system for the cannula, showcasing Willenkamp's commitment to enhancing intraocular treatment procedures.

Career Highlights

Working at Neovista Inc., Sabine Willenkamp has been instrumental in the development of innovative medical solutions. Her contributions to the field reflect her dedication to improving patient care through advanced technology.

Collaborations

Throughout her career, Willenkamp has collaborated with esteemed professionals such as Charles E. Larsen and Richard A. Hillstead. These partnerships have played a vital role in the successful development and implementation of her patented technologies.

Conclusion

Sabine Willenkamp's work exemplifies the spirit of innovation in medical technology. Her patents not only showcase her ingenuity but also signify the potential improvements in treatment methods for patients undergoing intraocular procedures. With her continued contributions, the field can expect further advancements that enhance both safety and efficacy in medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…